Medicure International Enter Agreement with Reliance Life Sciences for Cardiovascular Biosimilar

Yesterday, Medicure, Inc. announced that its wholly-owned subsidiary, Medicure International Inc., has entered into a license, manufacture and supply agreement with Reliance Life Sciences Private Limited for a cardiovascular biosimilar. The identity of the biosimilar was not disclosed.  Medicure will be responsible for the regulatory approval process for the biosimilar.